Safety and tolerability of montelukast in placebo-controlled pediatric studies and their open-label extensions
Pediatric Pulmonology 44:568–579 (2009)Safety and Tolerability of Montelukast inHans Bisgaard, MD, DMSci,1* David Skoner, MD,2 Maria L. Boza, MD,3 Carol A. Tozzi, PhD,4MD,4 Barbara Knorr, MD,4 and Gertrude Noonan, BASummary. Background: Montelukast is a potent leukotriene-receptor antagonist administeredonce daily that provides clinical benefit in the treatment of asthma and allergic rhiniti